Volume 11, Issue 3 (Autumn 2007)                   2007, 11(3): 51-56 | Back to browse issues page

XML Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Sheikholeslami H, Ziaee A, Darvishghaderi S, Vahedi S. Hypothyroidism and type 1 diabetes mellitus. Journal of Inflammatory Diseases. 2007; 11 (3) :51-56
URL: http://journal.qums.ac.ir/article-1-53-en.html
1- , E mail: h_sheikholeslami@yahoo.com
Abstract:   (10367 Views)
Abstract Background: Type 1 diabetes mellitus is frequently associated with autoimmune thyroid disease. Genetic susceptibility to autoantibody formation in association with autoimmune thyroid disease and type 1 diabetes mellitus has been described with varying frequencies. Objective: To investigate the prevalence of anti-thyroid peroxidase (anti-TPO) and also the overt and subclinical hypothyroidism in type 1 diabetic patients. Methods: In this case-control study, 65 subjects with type 1 diabetes mellitus and 65 unrelated normal controls were recruited for detection of anti-TPO and thyroid-stimulating hormone (TSH). Radioimmunoassay (RIA) was used for anti-TPO and TSH detection. Findings: Out of 65 type 1 diabetic patients, 18 (27.7%) were positive for anti-TPO and 18 (27.7%) with abnormal serum TSH level. Among the patient group, 11 (16%) were found to have overt hypothyroidism and 7 (10.8%) with subclinical hypothyroidism. The mean anti-TPO levels were higher in patients with overt hypothyroidism (238.18±223.69 U/ml) than in patients with subclinical hypothyroidism (36.38±22.46 U/ml). Of a total of 11 patients with overt hypothyroidism, 9 (81.1%) showed abnormal anti-TPO levels, whereas positive anti-TPO was detected in 57% (4 out of 7) of patients with subclinical hypothyroidism. Conclusion: The presence of anti-TPO in 27.7% of type 1 diabetic patients confirmed a strong association between autoimmune thyroid disease and type 1 diabetes mellitus. Thus, for early detection of autoimmune thyroid disease in patients with type 1 diabetes mellitus, the measurement of anti-TPO and TSH, preferably at the onset of disease, is recommended.
Full-Text [PDF 106 kb]   (2645 Downloads)    
Type of Study: Research | Subject: ENT

Add your comments about this article : Your username or Email:

Send email to the article author

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2023 CC BY-NC 4.0 | Journal of Inflammatory Diseases

Designed & Developed by : Yektaweb